REFERENCES
1. Jelkmann W. Autologous red blood cell transfusions in clinics and their misuse in sports. Dtsch Z Sportmed. 2020;71:62-8.
2. Malm CB, Khoo NS, Granlund I, Lindstedt E, Hult A, Connes P. Autologous doping with cryopreserved red blood cells - effects on physical performance and detection by multivariate statistics. PLoS ONE. 2016;11:e0156157.
3. World Anti-Doping Agency. World anti-doping code. Montreal: WADA; 2021. Available from: https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf. [Last accessed on 17 Nov 2025].
4. World Anti-Doping Agency. Prohibited list 2024. Montreal: World Anti-Doping Agency; 2024. Available from: https://www.wada-ama.org/sites/default/files/2023-09/2024list_en_final_22_september_2023.pdf. [Last accessed on 17 Nov 2025].
5. Nelson M, Popp H, Sharpe K, Ashenden M. Proof of homologous blood transfusion through quantification of blood group antigens. Haematologica. 2003;88:1284-95.
6. Krumm B, Saugy JJ, Botrè F, Donati F, Faiss R. Indirect biomarkers of blood doping: A systematic review. Drug Test Anal. 2023;16:49-64.
7. World Anti-Doping Agency. Athlete biological passport operating guidelines. Available from: https://www.wada-ama.org/sites/default/files/resources/files/guidelines_abp_v71.pdf. [Last accessed on 18 Nov 2025].
8. Cyclingnews. Operation aderlass doctor mark schmidt jailed for almost five years. Available from: https://www.cyclingnews.com/news/operation-aderlass-doctor-mark-schmidt-jailed-for-almost-five-years/. [Last accessed on 18 Nov 2025].
9. Riedmaier I, Pfaffl MW, Meyer HHD. The physiological way: monitoring RNA expression changes as new approach to combat illegal growth promoter application. Drug Test Anal. 2012;4:70-4.
10. Riedmaier I, Spornraft M, Pfaffl MW. Identification of a potential gene expression biomarker signature in bovine liver to detect the abuse of growth promoters. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31:641-9.
11. Neuberger E, Mooses M, Durussel J, et al. Small RNA sequencing of red blood cell specific miRNAs reveals expression changes after 6 weeks of recombinant EPO (rEPO) administration in healthy recreational athletes. Available from: https://research.brighton.ac.uk/en/publications/small-rna-sequencing-of-red-blood-cell-specific-mirnas-reveals-ex/. [Last accessed on 18 Nov 2025].
12. Leuenberger N, Jan N, Pradervand S, Robinson N, Saugy M. Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse. Drug Test Anal. 2011;3:771-6.
14. Friedman RC, Farh KH, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92-105.
15. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835-40.
16. Chen SY, Wang Y, Telen MJ, Chi JT, Zhang B. The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS ONE. 2008;3:e2360.
17. Sangokoya C, LaMonte G, Chi JT. Isolation and characterization of microRNAs of human mature erythrocytes. Methods Mol Biol. 2010;667:193-203.
18. Sarachana T, Kulkarni S, Atreya CD. Evaluation of small noncoding RNAs in ex vivo stored human mature red blood cells: changes in noncoding RNA levels correlate with storage lesion events. Transfusion. 2015;55:2672-83.
19. Haberberger A, Kirchner B, Riedmaier I, et al. Changes in the microRNA expression profile during blood storage. BMJ Open Sport Exerc Med. 2018;4:e000354.
20. Kannan M, Atreya C. Differential profiling of human red blood cells during storage for 52 selected microRNAs. Transfusion. 2010;50:1581-8.
21. Wannez A, Devalet B, Chatelain B, Chatelain C, Dogné JM, Mullier F. Extracellular vesicles in red blood cell concentrates: an overview. Transfus Med Rev. 2019;33:125-30.
22. Voss SC, Jaganjac M, Al‐thani AM, et al. Analysis of RBC‐microparticles in stored whole blood bags - a promising marker to detect blood doping in sports? Drug Test Anal. 2017;9:1794-8.
23. Kuo WP, Tigges JC, Toxavidis V, Ghiran I. Red blood cells: a source of extracellular vesicles. Methods Mol Biol. 2017;1660:15-22.
24. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9.
25. Skog J, Würdinger T, Van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-6.
26. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161-72.
27. Brzozowski JS, Jankowski H, Bond DR, et al. Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines. Lipids Health Dis. 2018;17:211.
28. Huang X, Yuan T, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319.
29. Jimenez L, Barman B, Jung YJ, et al. Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations. J Extracell Vesicles. 2023;12:e12366.
30. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-8.
31. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223-33.
32. Barutta F, Tricarico M, Corbelli A, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE. 2013;8:e73798.
33. Long JD, Sullivan TB, Humphrey J, et al. A non-invasive miRNA based assay to detect bladder cancer in cell-free urine. Am J Transl Res. 2015;7:2500-9. Available from: https://www.ajtr.org/files/ajtr0015857.pdf. [Last accessed on 18 Nov 2025].
34. Khurana R, Ranches G, Schafferer S, et al. Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA. 2017;23:142-52.
35. Solé C, Cortés-hernández J, Felip ML, Vidal M, Ordi-ros J. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant. 2015;30:1488-96.
36. Cheng Y, Wang X, Yang J, et al. A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol. 2012;53:668-76.
37. Dhondt B, Van Deun J, Vermaerke S, et al. Urinary extracellular vesicle biomarkers in urological cancers: from discovery towards clinical implementation. Int J Biochem Cell Biol. 2018;99:236-56.
38. World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-4.
39. World Anti-Doping Agency. Urine sample collection guidelines. Available from: https://www.wada-ama.org/sites/default/files/resources/files/wada_guidelines_urine_sample_collection_2014_v1.0_en.pdf. [Last accessed on 18 Nov 2025].
40. World Anti-Doping Agency. Guidelines for sample collection. Available from: https://www.wada-ama.org/sites/default/files/2023-11/sample_collection_final.pdf. [Last accessed on 18 Nov 2025].
41. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
42. Welsh JA, Goberdhan DCI, O'driscoll L, et al. MISEV consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
43. Mussack V, Wittmann G, Pfaffl MW. On the trail of blood doping - fingerprints to monitor autologous blood transfusions in vivo. Am J Hematol. 2021;96:338-53.
44. Department of Health, Education, and Welfare, National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The belmont report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent. 2014;81:4-13.
45. Rosner B. Fundamentals of biostatistics. Cengage Learning; 2010. Available from: https://studylib.net/doc/27109472/fundamentals-of-biostatistics--7th-edition-. [Last accessed on 18 Nov 2025].
46. Bundesanzeiger Verlag. Bekanntmachung der neufassung des transfusionsgesetzes. Available from: https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&bk=Bundesanzeiger_BGBl&start=//*[@attr_id=%27bgbl107s2169.pdf%27]#/switch/tocPane?_ts=1763430811235. [Last accessed on 18 Nov 2025].
47. Erdbrügger U, Blijdorp CJ, Bijnsdorp IV, et al. Urinary extracellular vesicles: a position paper by the Urine Task Force of the International Society for Extracellular Vesicles. J Extracell Vesicles. 2021;10:e12093.
49. Zhou H, Yuen P, Pisitkun T, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006;69:1471-6.
50. Delanghe JR, Speeckaert MM. Creatinine determination according to Jaffe--what does it stand for? NDT Plus. 2011;4:83-6.
51. Mussack V, Wittmann G, Pfaffl MW. Comparing small urinary extracellular vesicle purification methods with a view to RNA sequencing - enabling robust and non-invasive biomarker research. Biomol Detect Quantif. 2019;17:100089.
52. Eitan E, Green J, Bodogai M, et al. Age-related changes in plasma extracellular vesicle characteristics and internalization by leukocytes. Sci Rep. 2017;7:1342.
53. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289-300. Available from: https://www.jstor.org/stable/2346101. [Last accessed on 18 Nov 2025].
54. BD Biosciences. FlowJoTM software. Available from: https://www.bdbiosciences.com/en-us/products/software/flowjo-software?tab=flowJo-v11-software. [Last accessed on 18 Nov 2025].
55. Kolde R. pheatmap: Pretty heatmaps. Available from: https://raivokolde.r-universe.dev/pheatmap. [Last accessed on 18 Nov 2025].
56. R Core Team. The R project for statistical computing. Available from: https://www.r-project.org/. [Last accessed on 18 Nov 2025].
57. Schroeder A, Mueller O, Stocker S, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3.
58. Andrews S. FastQC: a quality control tool for high throughput sequence data. Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/. [Last accessed on 18 Nov 2025].
59. Kong Y. Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies. Genomics. 2011;98:152-3.
60. Petrov AI, Kay SJE, Kalvari I, et al. RNAcentral: a comprehensive database of non-coding RNA sequences. Nucleic Acids Res. 2017;45:D128-34.
61. Kozomara A, Griffiths-jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68-73.
62. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.
64. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
65. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
66. Wickham H. ggplot2: elegant graphics for data analysis. Springer-Verlag New York; 2016. Available from: https://ggplot2-book.org/. [Last accessed on 18 Nov 2025].
67. Van Deun J, Mestdagh P, Agostinis P, et al. EV-TRACK Consortium. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14:228-32.
68. Koliha N, Wiencek Y, Heider U, et al. A novel multiplex bead‐based platform highlights the diversity of extracellular vesicles. J Extracell Vesicles. 2016;5:29975.
69. Willekens FLA, Werre JM, Kruijt JK, et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood. 2005;105:2141-5.
70. Yáñez‐mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
71. Voss SC, Yassin M, Grivel JC, et al. Red blood cell derived extracellular vesicles during the process of autologous blood doping. Drug Test Anal. 2021;14:1984-94.
72. Dimuccio V, Ranghino A, Praticò Barbato L, et al. Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS ONE. 2014;9:e104490.
73. Keller S, Rupp C, Stoeck A, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007;72:1095-102.
74. Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol. 1988;6:629-62.
75. Altin JG, Sloan EK. The role of CD45 and CD45-associated molecules in T cell activation. Immunol Cell Biol. 1997;75:430-45.
76. Mussack V. The role of microRNAs and extracellular vesicles in the detection of autologous blood doping. Available from: https://mediatum.ub.tum.de/doc/1615908/document.pdf. [Last accessed on 18 Nov 2025].
77. Pacurari M, Tchounwou PB. Role of microRNAs in renin-angiotensin-aldosterone system-mediated cardiovascular inflammation and remodeling. Int J Inflam. 2015;2015:101527.
78. Liu HH, Li XQ, Liu JF, et al. miR-6869-5p transported by plasma extracellular vesicles mediates renal tubule injury and renin-angiotensin system activation in obesity. Front Med. 2021;8:725598.
79. Shen M, Chen T, Li X, et al. The role of miR-155 in urologic malignancies. Biomed Pharmacother. 2024;174:116412.
80. Jafarzadeh A, Naseri A, Shojaie L, et al. MicroRNA-155 and antiviral immune responses. Int Immunopharmacol. 2021;101:108188.
81. Zingale VD, Gugliandolo A, Mazzon E. MiR-155: an important regulator of neuroinflammation. Int J Mol Sci. 2021;23:90.
82. Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun. 2007;364:509-14.
83. Ali H, Malik MZ, Abu‐farha M, et al. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease. J Gene Med. 2024;26:e3674.
